©2024 Lysando

All rights reserved

Finally, a Future Without Fear Is Within Your Reach!

Our pathway


Ingredient Developer

Artilysin® as a platform technology reaches across various indications and applications from Acne to Sepsis, from Mastitis to VAP. Lysando‘s focus is currently on the following main topics.


Millions of patients around the world suffer from persistent, infected and potentially life-threatening wounds. They are not only painful, but also restrict the life of every individual. The patients are exhausted – socially, physically and emotionally.


The common cause are bacterial pathogens that hinder the patients’ pain-free lives. Wound care can rapidly become more complicated when doctors have to combat infections caused by antibiotic-resistant bacteria. Pathogens, such as Staphylococcus aureus, develop resistance to one or more antibiotics.


This makes the treatment of chronic wounds immensely more difficult and results in a serious and permanent health risk for the patient. In Germany alone, over 1 million people suffer from chronic wounds.


Atopic dermatitis is a chronic, relapsing, and lifelong inflammatory and eczematous skin disease. The currently available treatment options are not effective or have significant or adverse side effects. Symptoms include red and dry patches of skin, which may ooze or bleed when scratched, as well as thickening and hardening of the skin.


The cause of AD is still not fully understood. Research suggests that changes in the protective layer of the skin can cause it to become dry, which may lead to damage and inflammation. Scratching the skin can further exacerbate the damage and increase the risk of bacterial infection. Scientists increasingly link Staphylococcus aureus to the severity of atopic dermatitis. In many individuals with severe symptoms, 70% of the skin is colonized with Staphylococcus aureus.


Worldwide, approximately 2.4% of humans suffer from atopic dermatitis, with the majority being children. Like many other chronic disorders, AD can have serious psychological effects on patients, such as depression, anxiety, and social isolation.


Urinary tract infections (UTIs) are infections of the bladder and kidneys. Antibiotics are typically the first line of treatment for UTIs, although there is a rise in the prevalence of resistant bacterial strains.


UTIs are predominantly caused by Escherichia coli strains that are increasingly becoming resistant to antibiotics.


Every year, approximately 150 million UTIs occur worldwide, with a 60% probability of becoming chronic. Women are particularly affected, accounting for over 80% of all cases.

Close to Revenue Projects

Our primary strategic objective is to develop human pharmaceutical products for treating bacterial infections. However, considering the platform nature and superior technology of the Artilysin® platform, as well as for risk mitigation purposes, Lysando has concurrently pursued two projects with significantly shorter development timelines. These projects are anticipated to generate revenue prior to the market launch of our initial human pharmaceutical product:


Acne is caused by sebaceous glands being clogged with dead skin cells and oil from the skin. There are different types of acne like Acne vulgaris or Acne tarde. Acne vulgaris is the most frequent dermatosis in adolescence with a prevalence of almost 90%.


Within these sebaceous glands, Cutibacterium acnes is the most prevalent and abundant species, representing approximately 90% of the local skin microbiome. Although being part of the healthy skin microbiome, C. acnes is directly involved in the disease pathogenesis of acne.


Acne is the most common dermatological disorder worldwide and over 780 million people globally bear the burden of it. Acne causes physical and mental pain for the affected people in many different ways.

And Now
You Come In

We are Offering You the Chance to Join Us in Creating a Healthier Future for Us All

Your Support Will Make a Real Difference in the World:


By creating a world where bacterial infections no longer pose a threat to our lives

By protecting everyone in our society and enabling them to live longer and healthier lives

By ensuring that bacterial infections can be treated in a more sustainable and tolerable way

By creating a new standard in medicine, one which takes away the fear of a hospital visit

By stopping the further increase of antibiotic contamination of animal-based food

By reducing the amount of antibiotic residues entering our oceans and environment

But most of all, we will create a world free from the fear of disease-causing bacteria – and save millions of lives.

Here’s How You Can Support Us

Spread the word and inform your friends and family about us.

Ask your doctors and pharmacists if they are familiar with our technology and encourage them to reach out to us for further information.

Let’s Join Forces!

Want to Do More?

Then ask your doctors and pharmacists if they already know about our technology – and encourage them to contact us for further information.